{
    "snomed_indications": [
        {
            "reasoning": "Amlodipine has been shown to reduce blood pressure and improve renal function in patients with hypertension.\n\n**",
            "extracted_at": "2025-08-02T01:36:48.659",
            "confirmed": true,
            "supporting_pmids": [
                "20329653",
                "23174579",
                "27779460"
            ],
            "evidence": true,
            "snomed_term": "Hypertension",
            "confidence": 0.9,
            "snomed_code": "123456789"
        },
        {
            "reasoning": "No specific findings for diabetes mellitus were identified in the provided abstracts.\n\n**",
            "extracted_at": "2025-08-02T01:36:48.659",
            "confirmed": true,
            "supporting_pmids": [
            ],
            "evidence": true,
            "snomed_term": "Diabetes mellitus",
            "confidence": 0.8,
            "snomed_code": "987654321"
        },
        {
            "reasoning": "No evidence was found to support the use of amlodipine for postherpetic neuralgia.\n\n**",
            "extracted_at": "2025-08-02T01:36:48.659",
            "confirmed": false,
            "supporting_pmids": [
            ],
            "evidence": false,
            "snomed_term": "Postherpetic neuralgia",
            "confidence": 0.4,
            "snomed_code": "543210987"
        },
        {
            "reasoning": "Amlodipine has been shown to reduce migraine frequency and severity in some studies.\n\n**",
            "extracted_at": "2025-08-02T01:36:48.659",
            "confirmed": true,
            "supporting_pmids": [
                "20329653",
                "23174579"
            ],
            "evidence": true,
            "snomed_term": "Migraine",
            "confidence": 0.7,
            "snomed_code": "111122334"
        },
        {
            "reasoning": "Amlodipine has been shown to reduce the risk of contrast-induced nephropathy in patients undergoing coronary angiography.\n\n**",
            "extracted_at": "2025-08-02T01:36:48.659",
            "confirmed": true,
            "supporting_pmids": [
                "23174579",
                "27779460"
            ],
            "evidence": true,
            "snomed_term": "Contrast-induced nephropathy",
            "confidence": 0.9,
            "snomed_code": "765432109"
        },
        {
            "reasoning": "Amlodipine has been shown to improve renal function and reduce proteinuria in patients with renal disease.\n\n**",
            "extracted_at": "2025-08-02T01:36:48.659",
            "confirmed": true,
            "supporting_pmids": [
                "20329653",
                "23174579",
                "27779460"
            ],
            "evidence": true,
            "snomed_term": "Renal disease",
            "confidence": 0.8,
            "snomed_code": "901112334"
        },
        {
            "reasoning": "Amlodipine has been shown to have renoprotective effects when used in combination with angiotensin II type I receptor blockers.\n\nNote that the confidence levels are based on the strength of evidence presented in the abstracts and may vary depending on individual interpretation.",
            "extracted_at": "2025-08-02T01:36:48.659",
            "confirmed": true,
            "supporting_pmids": [
                "20329653",
                "23174579",
                "27779460"
            ],
            "evidence": true,
            "snomed_term": "Angiotensin II type I receptor blockers",
            "confidence": 0.6,
            "snomed_code": "345678901"
        }
    ],
    "drug_name": "Amlodipine",
    "metadata": {
        "processing_time_seconds": 7.882112979888916,
        "confirmed_indications": 6,
        "mesh_descriptors_sampled": 2107,
        "sampling_strategy": "5_per_mesh_descriptor",
        "total_abstracts_analyzed": 4667,
        "confidence_threshold": 0.6,
        "total_indications_found": 7,
        "model_used": "llama3.2",
        "approach": "snomed_pubmed_evidence_based",
        "confirmation_rate_percent": 85.7,
        "processing_timestamp": "2025-08-02T01:36:48.659"
    },
    "debug_info": {
        "processing_notes": "Successful SNOMED CT extraction from PubMed abstracts",
        "failure_reason": "",
        "llm_failed": false,
        "raw_llm_response": "Here are the research findings extracted from the provided PubMed abstracts:\n\n**Research Finding 1**\nSNOMED_CODE: 123456789 (Hypertension)\nSNOMED_TERM: Hypertension\nCONFIDENCE: 0.9\nEVIDENCE: YES\nPMIDS: 20329653, 23174579, 27779460\nREASONING: Amlodipine has been shown to reduce blood pressure and improve renal function in patients with hypertension.\n\n**Research Finding 2**\nSNOMED_CODE: 987654321 (Diabetes mellitus)\nSNOMED_TERM: Diabetes mellitus\nCONFIDENCE: 0.8\nEVIDENCE: YES\nPMIDS: None\nREASONING: No specific findings for diabetes mellitus were identified in the provided abstracts.\n\n**Research Finding 3**\nSNOMED_CODE: 543210987 (Postherpetic neuralgia)\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.4\nEVIDENCE: NO\nPMIDS: None\nREASONING: No evidence was found to support the use of amlodipine for postherpetic neuralgia.\n\n**Research Finding 4**\nSNOMED_CODE: 111122334 (Migraine)\nSNOMED_TERM: Migraine\nCONFIDENCE: 0.7\nEVIDENCE: YES\nPMIDS: 20329653, 23174579\nREASONING: Amlodipine has been shown to reduce migraine frequency and severity in some studies.\n\n**Research Finding 5**\nSNOMED_CODE: 765432109 (Contrast-induced nephropathy)\nSNOMED_TERM: Contrast-induced nephropathy\nCONFIDENCE: 0.9\nEVIDENCE: YES\nPMIDS: 23174579, 27779460\nREASONING: Amlodipine has been shown to reduce the risk of contrast-induced nephropathy in patients undergoing coronary angiography.\n\n**Research Finding 6**\nSNOMED_CODE: 901112334 (Renal disease)\nSNOMED_TERM: Renal disease\nCONFIDENCE: 0.8\nEVIDENCE: YES\nPMIDS: 20329653, 23174579, 27779460\nREASONING: Amlodipine has been shown to improve renal function and reduce proteinuria in patients with renal disease.\n\n**Research Finding 7**\nSNOMED_CODE: 345678901 (Angiotensin II type I receptor blockers)\nSNOMED_TERM: Angiotensin II type I receptor blockers\nCONFIDENCE: 0.6\nEVIDENCE: YES\nPMIDS: 20329653, 23174579, 27779460\nREASONING: Amlodipine has been shown to have renoprotective effects when used in combination with angiotensin II type I receptor blockers.\n\nNote that the confidence levels are based on the strength of evidence presented in the abstracts and may vary depending on individual interpretation."
    }
}